US Stock MarketDetailed Quotes

ASRT Assertio

Watchlist
  • 0.776
  • -0.023-2.90%
Close Feb 28 16:00 ET
  • 0.800
  • +0.024+3.11%
Post 19:12 ET
74.08MMarket Cap-1.76P/E (TTM)

About Assertio Company

Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.

Company Profile

SymbolASRT
Company NameAssertio
Listing DateDec 2, 1997
Founded1995
CEOMs. Heather L. Mason
MarketNASDAQ
Employees53
Fiscal Year Ends12-31
Address100 South Saunders Road,Suite 300
CityLake Forest
ProvinceIllinois
CountryUnited States of America
Zip Code60045
Phone1-224-419-7106
Websitehttp://www.assertiotx.com

Company Executives

  • Name
  • Position
  • Salary
  • Brendan P. O’Grady
  • Co-Chief Executive Officer
  • --
  • Ajay Patel
  • Senior Vice President, Chief Financial Officer and Chief Accounting Officer
  • 1.06M
  • Paul Schwichtenberg
  • Chief Transformation Officer
  • 1.09M
  • Mary Pietryga
  • Chief Commercial Officer
  • --
  • Sam Schlessinger
  • Senior Vice President and General Counsel
  • --
  • Heather L. Mason
  • Chairman of the Board
  • 353.02K
  • Mark Reisenauer
  • Director
  • --
  • Sigurd C. Kirk
  • Independent Director
  • --
  • William T. Mckee
  • Independent Director
  • 356.52K
  • James L. Tyree
  • Independent Director
  • 346.89K
  • Sravan K. Emany
  • Independent Director
  • 223.80K
  • David Matthew Stark
  • Independent Director
  • --

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
LINTEX
920106
+30.00%
LINGOOD
833284
+29.98%
NTGEC
870436
+29.98%
4
CG MED EQUIP.
838810
+29.97%
5
Jiayu Holding
300117
+20.48%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More
FOMC Press Conference, January 29, 2025